Open an account

CapsoVision

CV · NASDAQ

$6.68+$0.01 (+0.15%)TodayMarket closed ·
Prev close $6.67

About CV

CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California and currently employs 28 full-time employees. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.

Employees
28
Headquarters
Saratoga California, California
Listed
Jul 2, 2025
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
capsovision.com

CV key statistics

Market cap
355.45M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
153.53K
Volume
62.35K
Open price
$6.70
High today
$6.78
Low today
$6.68
52 Week high
$15.37
52 Week low
$4.50

CapsoVision (CV) at a glance

CapsoVision (CV) last traded at $6.68, with a market cap of 355.45M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $6.68 and $6.78. The current price is 0.0% above the day's low and 1.5% below its high.

Volume so far is 62.35K shares, below the average of 153.53K shares a day.

Over the past year CapsoVision has ranged from $4.50 to $15.37, and now sits 20% of the way up that range.

CapsoVision met or beat analyst EPS estimates in 1 of the last 5 quarters. In Q2 FY26 it reported -$0.15 per share against an estimate of -$0.1339.

The average analyst price target is $9.69, 45.1% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 5 analystsAvg $9.69
Low
$9.09
Now
$6.68
High
$10.50

CV earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 5 quarters, by 86.6% on average.

  1. Q2 FY25: reported -$2.02 per share against an estimate of -$0.1133
  2. Q3 FY25: reported -$0.17 per share against an estimate of -$0.1288
  3. Q4 FY25: reported -$0.02 per share against an estimate of -$0.1493
  4. Q1 FY26: reported -$0.15 per share against an estimate of -$0.1339
  5. Q2 FY26: reported -$0.15 per share against an estimate of -$0.1339

CV news

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • Avi Kapoor

    Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

  • Avi Kapoor

    Why ZIM Integrated Shipping Services Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

  • Avi Kapoor

    Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Rishabh Mishra

    As Warren Buffett And Other Billionaires Load Up On Energy Stocks, This Analyst Highlights Charlie Munger's 1962 Oil Investment Which Can 'Outperform All The Rest'

Similar companies

Companies in the same industry as CapsoVision

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.